Skip to main content


The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

What's new

How are the bacteria in our gut related to type 2 diabetes and obesity? The fascinating research. Continue Reading »

The Future of Type 1 Diabetes – what challenges and promises lie ahead? Part two of our interview with David Panzirer and Dana Ball. Continue Reading »

On April 24, Hyperion Therapeutics announced that it would acquire Andromeda Biotech. Andromeda is focused on the... Continue Reading »

Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball. Continue Reading »

Dr. Damiano reveals the much anticipated data from the bionic pancreas trials at the biggest diabetes tech conference of the year. Continue Reading »